Catherine Moukheibir

Insider profile

Currently holds positions in Ablynx NV, GenKyoTex SA and Ironwood Pharmaceuticals, Inc.

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return -7% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
8 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Ablynx NV Sept. 2, 2013 -
Independent Director GenKyoTex SA Feb. 28, 2017 -
Independent Director Ironwood Pharmaceuticals, Inc. April 1, 2019 -
Executive Vice President, Member of the Executive Board, Consultant Senior Finance Advisor Innate Pharma SA May 5, 2011 - Dec. 30, 2016
Catherine Moukheibir's trades of MoonLake Immunotherapeutics's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
387.96
Quantity 78,195
Value US$2,289,813
Transaction date
Purchase
Price
2.74
Quantity 7,226
Value £19,821
Transaction date
Purchase
Price
4.30
Quantity 6,684
Value £28,741
Transaction date
Purchase
Price
3.17
Quantity 8,910
Value £28,245
Transaction date
Purchase
Price
5.71
Quantity 2,467
Value £14,084
Transaction date
Sale
Price
15.80
Quantity 38
Value €608
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-07 2025-07-03
S Sale
15,057 -20.0%
206.67
US$2,439,409 		15,057 -20.0% 206.67 US$2,439,409
2025-07-03 2025-07-03
PrS Proposed sale
78,195
387.96
US$2,289,813 		78,195 387.96 US$2,289,813
2024-06-10 2024-06-07
S Sale
77,350 -5.8%
190.50
US$4,552,455 		77,350 -5.8% 190.50 US$4,552,455
2024-06-07 2024-06-07
PrS Proposed sale
35,574
6.60
US$234,767 		35,574 6.60 US$234,767
2024-06-10 2024-06-06
S Sale
44,426 -34.5%
6.36
US$282,549 		44,426 -34.5% 6.36 US$282,549
2024-06-06 2024-06-06
PrS Proposed sale
44,426
6.36
US$282,490 		44,426 6.36 US$282,490
2023-09-20 2023-09-20
B Purchase
7,226
2.74
£19,821 		7,226 2.74 £19,821
2023-07-03 2023-07-03
B Purchase
6,684
4.30
£28,741 		6,684 4.30 £28,741
2022-10-12 2022-10-11
B Purchase
8,910
3.17
£28,245 		8,910 3.17 £28,245
2022-04-29 2022-04-29
B Purchase
2,467
5.71
£14,084 		2,467 5.71 £14,084
2015-06-08 2015-05-28
S Sale
38
15.80
€608 		38 15.80 €608